Document is current
Any future updates will be listed below
-
Authors
Kondo, Masaaki http://orcid.org/0000-0002-6063-4561
Morimoto, Manabu
Kobayashi, Satoshi
Ohkawa, Shinichi
Hidaka, Hisashi
Nakazawa, Takahide
Aikata, Hiroshi
Hatanaka, Takeshi
Takizawa, Daichi
Matsunaga, Kotaro
Okuse, Chiaki
Suzuki, Michihiro
Taguri, Masataka
Ishibashi, Takako
Numata, Kazushi
Maeda, Shin
Tanaka, Katsuaki
-
Funding
Funding for this research was provided by:
Waksman Foundation of Japan
- License Information
-
More Information
Article History
Received: 21 March 2019
Accepted: 24 September 2019
First Online: 15 October 2019
Ethics approval and consent to participate
: This study was performed according to the guidelines of the Helsinki Declaration.This trial was reviewed and approved by the review board of Yokohama City University Medical Center on 22 July 2011: registration number D110721005. This was approved by the review board of all participating institutes which are:Kitasato University Hospital on 19 October 2011: registration number 11–696.St Marianna University School of Medicine on 24 November 2011: registration number 2003.St Marianna University School of Medicine, Yokohama City Seibu Hospital on 24 November 2011: registration number 2003.Kawasaki Municipal Tama Hospital, Yokohama City Seibu Hospital on 24 November 2011: registration number 2003.Kanagawa Cancer Center Hospital on 7 December 2011: registration number 41.Hiroshima University on 5 December 2012: registration number 363.Isesaki Municipal Hospital on 26 September 2013.Written informed consent was obtained from all the patients.
: Not applicable
: Morimoto received honoraria from Bayer and Okuse received honoraria from AbbVie. The other authors declare that they have no competing interests.
